Regulatory30 May 2026, 05:41 pm
Brawn Biotech: Reg 23(9) on Related Party Transactions Not Applicable
AI Summary
Brawn Biotech Ltd. reports that Regulation 23(9) concerning the filing of related party transactions is not applicable for the year ended March 31, 2026. As of March 31, 2026, the company's paid-up share capital was ₹3 Crores and net worth was approximately ₹4.32 Crores. This exemption is based on Regulation 15(2) of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, as the company's financials remained below the threshold of ₹10 Crore paid-up capital and ₹25 Crore net worth for the last three consecutive financial years.
Key Highlights
- Regulation 23(9) on related party transactions is not applicable to Brawn Biotech for FY26.
- Paid-up share capital is ₹3 Crores and net worth is ₹4.32 Crores as of March 31, 2026.
- Exemption is due to financials being below the specified threshold for three consecutive years.
- Company cites Regulation 15(2) of SEBI Listing Regulations as the basis for non-applicability.
Price Impact
More from BRAWN